Description
Flohale 0.5 mg Inhaler
Product Description
Flohale 0.5 mg inhaler is an inhalation therapy used for the ongoing management of asthma. It contains fluticasone propionate, a corticosteroid that helps reduce inflammation in the airways. By lowering swelling and irritation, it supports better airflow and helps decrease the frequency of asthma symptoms when used regularly as prescribed by a healthcare professional.
How Flohale 0.5 mg Inhaler Works
The Flohale 0.5 mg inhaler delivers fluticasone directly to the lungs, where it works to reduce inflammatory responses. This helps keep the airways open and lowers the likelihood of asthma flare-ups over time.
Key Benefits
- Supports long-term control of asthma symptoms
- Helps reduce airway inflammation and swelling
- Promotes improved breathing comfort
- Direct delivery of medication to the lungs
How to Use
- Use the inhaler exactly as prescribed by your healthcare provider
- Inhale the medication through the mouth using the inhaler device
- Avoid exhaling into the inhaler
- Use consistently at the same times each day
- Follow proper inhalation technique for best results
Important Safety Information
- Not intended for immediate relief of sudden asthma attacks
- Use a rescue inhaler for acute symptoms
- Do not stop use abruptly without medical advice
- Consult your healthcare provider if symptoms persist or worsen
Precautions
- Use with caution if you have a history of respiratory infections
- Inform your healthcare provider of any allergies or medications
- Monitor for side effects such as throat irritation or oral discomfort
Storage Instructions
Store at room temperature away from heat and moisture. Do not expose to extreme temperatures or freeze. Keep out of reach of children and use before the expiry date indicated on the packaging.
Additional Guidance
Regular use of the Flohale 0.5 mg inhaler is essential for maintaining asthma control. Routine follow-up with a healthcare provider can help ensure effective treatment and proper dosage adjustments when needed.
